Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

CTBO

Cantabio Pharmaceuticals (CE) (CTBO)

Cantabio Pharmaceuticals Inc (CE)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:USOTC:CTBO
DataHoraFonteTítuloCódigoCompanhia
21/06/201917:12Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
21/06/201917:09Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
21/06/201917:05Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
17/06/201915:20Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
24/05/201917:36Edgar (US Regulatory)Information Statement - All Other (definitive) (def 14c)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
15/05/201918:39Edgar (US Regulatory)Information Statements (revised) (prer14c)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
10/04/201916:14Edgar (US Regulatory)Statement of Ownership: Private Transaction (sc 13e3)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
22/03/201915:25Edgar (US Regulatory)Proxy Statement - Other Information (preliminary) (pre 14c)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
11/10/201818:08Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
11/10/201818:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
15/08/201811:09Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
16/07/201807:02Edgar (US Regulatory)Annual Report (10-k)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
29/06/201811:54Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
14/08/201707:01Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
14/07/201712:15Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
05/05/201718:10Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
04/05/201707:10Edgar (US Regulatory)Withdrawal of Registration Statement (rw)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
15/06/201608:00InvestorsHub NewsWireIndoor Harvest Corp (OTCQB: INQD) $25 million Sales Pipeline – $10 million ContractsUSOTC:CTBOCantabio Pharmaceuticals Inc (CE)
23/03/201617:42Edgar (US Regulatory)Amended Quarterly Report (10-q/a)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
20/07/201517:22Edgar (US Regulatory)Information Statement - Contested Solicitations (preliminary) (prec14c)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
16/07/201513:47Edgar (US Regulatory)Statement Regarding Change in Majority of Directors Pursuant to Rule 14f-1 (sc 14f1)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
 Apresentando as notícias mais relevantes sobre:USOTC:CTBO